Kite Pharma, Inc.
Q2 2017 13F Holders
Symbol
KITE
CUSIP
49803L109
Type
Equity
Class
COM
Num filings
256
Total reported value, excl. options
$5.24 B
Compare 2017 Q2 to
2017 Q3
2017 Q1
2016 Q4
2016 Q3
2016 Q2
2016 Q1
2015 Q4
2015 Q3
2015 Q2
2015 Q1
2014 Q4
2014 Q3
2014 Q2
Manager
Report Date
Value ($000)
Shares
Option Type